POTASSIUM CHANNELS AS PHARMACOLOGICAL TARGETS IN CARDIOVASCULAR MEDICINE

被引:21
作者
ESCANDE, D [1 ]
HENRY, P [1 ]
机构
[1] UNIV PARIS 11, PHYSIOL CELLULAIRE LAB, CNRS, URA 1121, F-91405 ORSAY, FRANCE
关键词
K+ CHANNEL MODULATORS; SULFONYLUREAS; CLASS-III ANTIARRHYTHMIC DRUGS; K+ CHANNEL OPENERS; CARDIOPROTECTION;
D O I
10.1093/eurheartj/14.suppl_B.2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2 / 9
页数:8
相关论文
共 55 条
[1]   CLINICAL-PHARMACOLOGY OF POTASSIUM CHANNEL OPENERS [J].
ANDERSSON, KE .
PHARMACOLOGY & TOXICOLOGY, 1992, 70 (04) :244-254
[2]  
ARENA JP, 1988, MOL PHARMACOL, V34, P60
[3]  
ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.ne.11.030188.000525
[4]   PHARMACOLOGICAL EVIDENCE FOR A ROLE OF ATP-DEPENDENT POTASSIUM CHANNELS IN MYOCARDIAL STUNNING [J].
AUCHAMPACH, JA ;
MARUYAMA, M ;
CAVERO, I ;
GROSS, GJ .
CIRCULATION, 1992, 86 (01) :311-319
[5]   ISOLATED ATRIAL MYOCYTES - ADENOSINE AND ACETYLCHOLINE INCREASE POTASSIUM CONDUCTANCE [J].
BELARDINELLI, L ;
ISENBERG, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 244 (05) :H734-H737
[6]  
BEREGI JP, 1991, CARDIOVASC DRUG THER, V5, P309
[7]   REGULATION OF ARTERIAL TONE BY ACTIVATION OF CALCIUM-DEPENDENT POTASSIUM CHANNELS [J].
BRAYDEN, JE ;
NELSON, MT .
SCIENCE, 1992, 256 (5056) :532-535
[8]  
CARMELIET E, 1985, J PHARMACOL EXP THER, V232, P817
[9]  
CARMELIET E, 1989, Pfluegers Archiv European Journal of Physiology, V414, pS88, DOI 10.1007/BF00582254
[10]   STRUCTURE AND FUNCTION OF VOLTAGE-SENSITIVE ION CHANNELS [J].
CATTERALL, WA .
SCIENCE, 1988, 242 (4875) :50-61